Participated · Seed · Nov 2024

Persperity Health develops a sweat-sensing technology platform aimed at improving continuous health monitoring with a focus on women's health. The platform is designed to deliver real-time, actionable insights into hormonal health, fertility, and menopause. The technology is exclusively licensed from Caltech and was developed by Dr. Wei Gao and Dr. Cui Ye. The company is led by co-founders CEO Shiv Shukla, Dr. Wei Gao, and Dr. Heather Lukas, with clinical collaborator Dr. Pauline Maki. Persperity intends to use the newly raised funds to accelerate development of its sweat-sensing technology. The company is based in Los Angeles, CA.

Participated · Equity · Oct 2023

Connections Health Solutions operates crisis response centers and mobile crisis units across the United States, providing immediate-access behavioral health crisis care. The Connections Model combines medical and recovery-oriented treatment to connect people to resources and return them to their lives as quickly as possible. Led by CEO Colin LeClair, the company helps communities architect and operate behavioral health crisis care systems. The company closed a $28M growth financing and will use the funds to accelerate new market entry in response to community demand for value-based mental health crisis services. Connections also plans to invest the proceeds in development of new services and technology to expand its crisis care offerings.

Led · Equity · Mar 2023

Wellvana Health offers a care model that helps independent primary care physicians, specialists, and health systems deliver care through flexible partnership structures such as acquisitions, joint ventures, or affiliate models. The company provides providers a range of partnership options while supporting clinical and operational needs across partners. Wellvana currently serves health care providers in 22 states and manages lives across multiple payors. The company intends to use new funding to continue growth in existing markets and to expand into new U.S. geographies. Since November 2020 it has raised approximately $140M in total funding. Kyle Wailes is CEO and the company was founded in 2019. Wellvana is a high-performance clinically integrated physician network that brings together a select group of independent primary care physicians and specialists to provide coordinated, high-quality care. The network standardizes quality measures and holds physicians accountable to measurable performance standards while keeping clinicians independent (not employed). Wellvana emphasizes physician leadership and partnerships between primary care and specialty providers to align convenience, outcomes and cost for patients. The company plans to offer its network immediately to employers within the San Antonio geographic region, targeting self-insured employers to help bend the healthcare cost curve. Wellvana was founded and financed by healthcare executive Charlie Martin alongside prominent San Antonio physician leaders including Dr. Salah Jaafar and Dr. Jairo Melo; Michael Platek serves as CEO. Martin’s background includes founding Vanguard Health Systems, which he sold to Tenet Healthcare after operating Baptist Health System.

Led · Equity · Jan 2023

Monogram Health is a value-based specialty provider of in-home evidence-based care and benefit management services for patients with polychronic conditions, including chronic kidney disease and end-stage renal disease. Led by CEO Mike Uchrin, the company deploys an in-home care delivery model and a technology-driven array of evidence-based clinical services such as complex case and disease management, utilization management, and medication therapy management. Monogram has numerous value-based partnerships with health plans and risk-bearing providers to care for patients across 34 states and all insurance products. The company raised $375M in growth funding. It intends to use the proceeds to support widespread deployment of its in-home kidney and polychronic care delivery model and to expand its tech-driven clinical services. Monogram Health provides benefit management and at-home care delivery focused exclusively on chronic kidney disease (CKD) and end-stage renal disease (ESRD). The company partners with health plans to deliver an evidence-based renal care model of clinical managed services, including complex case and disease management, utilization management, and medication therapy management. Leveraging a technology and managed-services platform, Monogram's multidisciplinary clinical team of nurses, nephrologists, dieticians, pharmacists, and social workers coordinates with a patient’s entire care network to slow disease progression and manage individualized needs. Monogram currently operates its renal disease clinical managed services across 20 U.S. states and has built a national network of nephrologists that includes hundreds of specialists. In April the company opened an operations center in Arizona to support its growth in Western states. The company intends to use the Series B proceeds to accelerate business expansion. Monogram Health delivers an at-home renal care model and data-driven care management solutions including complex case management, utilization management, and medication therapy management for patients with chronic kidney and end-stage renal disease. The company partners with health plans, physician practices, dialysis providers and clinically integrated health systems to create personalized care plans and a national network of nephrologists. Monogram uses next-generation artificial intelligence and evidence-based criteria to delay disease progression, optimize transitions to dialysis or transplant, and improve outcomes. It currently operates renal disease care management programs across 20 states and reports a readmission rate for its patients that is half the national average. About 90% of Monogram patients are enrolled in Medicare Advantage plans. Monogram is based in Nashville, Tenn., and is privately held by Frist Cressey Ventures and Norwest Venture Partners. Monogram Health provides kidney disease care management through in-home visits and ongoing clinical engagement, using teams of nurses, social workers, nephrologists, and geriatricians. The company partners with health plans and a national network of nephrologists to deliver cost-effective, integrated care and to improve patient outcomes. Monogram uses next-generation artificial intelligence, clinically integrated care delivery, and personalized care planning to delay disease progression and support transitions to dialysis or pre-emptive transplant. It operates renal disease care management programs for thousands of patients across the U.S., including Humana Medicare Advantage and Commercial members in Louisiana and Mississippi. Monogram emphasizes home-based care to reduce hospitalizations and support vulnerable patients during the COVID-19 pandemic. The company is based in Nashville, Tenn.

Led · Equity · Oct 2022

Valera Health operates a virtual behavioral healthcare practice that delivers comprehensive, longitudinal care through a team-based model of licensed therapists, nurse practitioners, case managers and psychiatrists augmented by proprietary digital technology and analytics. The company emphasizes evidence-based treatment plans and a quality strategy aligned to NCQA HEDIS measures to manage patients across acuity levels, from mild depression to schizophrenia. Valera partners closely with health systems and health plans, and its payer/provider partnerships collectively cover over 50 million lives. It offers culturally-intentional care to BIPOC and LGBTQ+ communities via a diverse, multilingual provider network in which more than 50% of clinicians self-identify as Black, Hispanic, or Asian. Valera says the financing will enable expansion of access to high-quality behavioral health care and deepen partnerships with leading health systems and health plans. The company closed a $44.5M growth equity round in late 2022 as part of its current financial position. Valera Health is a NYC-based mental health company delivering tech-driven virtual services. It provides comprehensive longitudinal care via a team-based model of coaches, therapists, and medication prescribers augmented by proprietary digital technology and analytics. The company treats conditions ranging from mild depression to severe schizophrenia and offers personalized, culturally intentional care for rural and urban communities, including BIPOC and LGBTQ+ patients, through a diverse, multilingual provider network. Over the past twelve months Valera has partnered with health plans and provider groups covering over 12 million lives. Valera intends to use the newly raised $15M to expand operations and business reach and will be expanding to multiple states in the coming months. The company is led by co-founder and CEO Dr. Thomas Tsang. Valera Health is a Brooklyn, N.Y.-based tele-behavioral health service that delivers longitudinal, team-based clinical care using coaches, therapists and medication prescribers augmented by proprietary digital technology. Its care model provides personalized treatment across a spectrum from meditation to therapy to medications for patients with mild depression to severe schizophrenia. The multidisciplinary care team includes licensed social workers, mental health counselors, nurse practitioners, and psychiatrists. The company is led by CEO and co-founder Thomas Tsang, MD. Valera plans to use new capital for strategic market expansion and to grow existing services. The articles report total funding to date of $9M following the latest raise.